HealthCap
@HealthCapVC
HealthCap is a family of venture capital funds investing globally in life sciences and is one of the largest life science specialized VC's in Europe.
You might like
Dear friends of @HealthCapVC. We will suspend our Twitter. Communications will be through our website healthcap.eu and Linked-In linkedin.com/company/health…. Please follow us there.
Priothera - Positive mocravimod Phase 1b clinical data published in Transplantation and Cellular Therapy healthcap.eu/ycmp
Oncopeptides’ Pepaxti has been granted marketing authorization in the UK healthcap.eu/eyn9
Oncopeptides announces the market potential for Pepaxti in Europe healthcap.eu/7c2w
Vicore announces new data from the IPF AIR trial further strengthening the benefit-risk profile of C21 healthcap.eu/k36j
Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership healthcap.eu/0om5
Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen healthcap.eu/t21w
BONESUPPORT’s CERAMENT®G used in first U.S. patient cases healthcap.eu/ceec
Targovax - The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research – with updated publication info healthcap.eu/lxyf
Vicore selects new ATRAG as next Drug Candidate healthcap.eu/tui7
Vicore’s digital therapeutic for IPF patients shows nearly 50% anxiety reduction in pilot study healthcap.eu/ykv5
InCarda Therapeutics Announces Execution of Planned CEO Transition to Drive Next Phase of Corporate Growth healthcap.eu/rgch
Oncopeptides starts commercialization of Pepaxti in Europe – Germany first market healthcap.eu/4m0u
Targovax receives approval to proceed with the ONCOS-102 phase 2 melanoma study from the US FDA healthcap.eu/vdpo
Oncopeptides provides an update from the meeting with FDAs advisory committee ODAC healthcap.eu/wo57
Vicore announces that C21 promotes vascular function in humans healthcap.eu/0nsc
Sesen Bio and Carisma Therapeutics Announce Merger Agreement healthcap.eu/dinm
Briefing Book for ODAC meeting on benefit/risk profile of Pepaxto now published healthcap.eu/ik81
Aro Biotherapeutics Receives FDA Rare Pediatric Drug Designation for ABX1100 for the Treatment of Pompe Disease healthcap.eu/gj3l
Vicore provides an update on the ATTRACT-3 COVID-19 trial healthcap.eu/gtzr
United States Trends
- 1. #CashAppFriday N/A
- 2. Obamas N/A
- 3. Lion King N/A
- 4. Tim Scott N/A
- 5. Benghazi N/A
- 6. Truth Social N/A
- 7. Barack N/A
- 8. #trumpisaracist N/A
- 9. Sonny Jurgensen N/A
- 10. #FursuitFriday N/A
- 11. President of the United States N/A
- 12. Shinedown N/A
- 13. Stafford N/A
- 14. Karoline Leavitt N/A
- 15. The White House N/A
- 16. Staffer N/A
- 17. Maye N/A
- 18. #OpaliteMusicVideo N/A
- 19. #WearRedDay N/A
- 20. John Barron N/A
Something went wrong.
Something went wrong.